-
¹ØÓÚÁú8Ψһ¹ÙÍø
-
-
ÐÂÎŶ¯Ì¬
-
-
-
Éç»áÔðÈÎ
-
Ͷ×ÊÕß¹Øϵ
²úÆ·ÖÐÐÄ
ÁªÏµÁú8Ψһ¹ÙÍø
ÏúÊÛרÓãº
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
Methoxy PEG Hydrazide
²úÆ·´úºÅ£º
M-PEG-HZ
²úÆ·´¿¶È£º
¡Ý 95%
°ü×°¹æ¸ñ£º
1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©
·Ö×ÓÁ¿£º
5000 Da-30000 Da£¬µÈ
Òªº¦´Ê£º
ËùÊô·ÖÀࣺ
¿ÆÑпͻ§Ð¡ÅúÁ¿Ò»¼ü²É¹ºµØµã£¨Ð¡ÓÚ5¿Ë£©
- ²úÆ·ÃèÊö
- ²Î¿¼ÎÄÏ×
-
¡¡¡¡¼×Ñõ»ù¾ÛÒÒ¶þ´¼õ£»ùë¿ÉÒÔÓëÈ©»ù¡¢Íª»ùºÍôÊ»ù·´Ó¦£¬ÓÈÆä±»Ó¦ÓÃÓÚÓëÂÑ°×ÖÊÖеÄÌÇ»ù»¯Î»µã½øÐоÛÒÒ¶þ´¼»¯¡£
²úÆ·±àÂë
²úÆ·´úºÅ
A3060F
M-HZ-5000
A3096F
M-HZ-10K
A3059F
M-HZ-20K
A3065F
M-HZ-30K
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼ÌṩM-HZ·Ö×ÓÁ¿µÄ5000 Da£¬10000 Da£¬20000Da£¬30000 DaµÄ²úÆ·1¿ËºÍ10¿Ë°ü×°¡£
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Ìṩ·ÖװЧÀÍ£¬ÐèÒªÊÕÈ¡·Ö×°Óöȣ¬Èç¹ûÄúÐèÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ¡£
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄM-HA ²úÆ·£¬ÈçÄãÐèÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ¡£
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ¡£
-
¡¡¡¡References:
¡¡¡¡1. Zhou, Z., et al., Comparison of Site-Specific PEGylations of the N-Terminus of Interferon Beta-1b: Selectivity, Efficiency, and in Vivo/Vitro Activity, Bioconjugate Chemistry, 2013, 25(1): p. 138-146.
2.Han, XW, et al., Synthesis of End-Functionalized Poly (norbornenes) and Poly (ethylidene norbornenes) Using a Pd (II) Catalyst in Combination with Chain Transfer Agents. Organometallics. 2021.
²úƷѯ¼Û
Áú8Ψһ¹ÙÍø
ЧÀÍÈÈÏߣº+86-010-82156767
ÏúÊÛרÓãº+86-010-62983737
²úÆ·×Éѯ£ºsales@jenkem.com
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
΢ÐÅÃñÖÚºÅ
΢ÐÅÃñÖÚºÅ